Dr. Robert Tri Bao Diep, MD

Dr. Diep practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Diep's NPI, 1497140537, was assigned on April 6, 2015. Dr. Diep graduated from Renaissance School of Medicine at Stony Brook University in 2015. Dr. Diep holds California license A172103.

Dr. Diep's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Diep's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Diep to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account. Dr. Diep's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Diep practices, 4 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Diep's primary specialty in the NPI Registry, under taxonomy code 207RH0000X. The record also lists hematology. Dr. Diep is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Diep's licenses on file in 3 states: California, Washington and North Carolina.

Dmand AI lists chronic anemia, chronic leukemia, deep vein thrombosis (DVT), immune deficiency disease, lung cancer, neutropenia and purpura and thrombocytopenia among the conditions Dr. Diep treats.

CMS data shows 503 Medicare services from Dr. Diep across 9 procedure codes in 2024, for 364 Medicare patients. Medicare paid $59,553 for them.

CMS counts 364 Medicare patients who saw Dr. Diep in 2024. The largest group is 65 to 74, with 145 patients. 74% of them have high cholesterol, and 71% have high blood pressure. 27% are also on Medicaid. Their average risk score is 2.27, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Diep's median patient age at 52, with 54% women.

In 2024, Dr. Diep wrote 175 Medicare Part D claims for 49 patients. 41% of them were for generic drugs. CMS names the drug for 108 of them, across 5 drugs with 11 or more claims each, at $80,862 in total drug cost. In 2023, CMS named 71 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Diep for performance year 2024, reported as part of a group. Dr. Diep accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Diep as offering telehealth.

Dmand AI links 11 papers to Dr. Diep, published from 2015 to 2025. 2020 was the busiest year, with 2. The most frequent topics are Hemorrhage, Anticoagulants and Venous Thromboembolism. Dr. Diep has published most often in J Thromb Thrombolysis. Dr. Diep's most frequent co-authors are David A. Garcia, MD, Murat Osman Arcasoy, MD and Christopher Tsung-Jer Chen, MD.

CMS Open Payments shows 8 general payments to Dr. Diep from 3 drug and device companies from 2023 to 2025. Consulting fees make up the largest share, 49% of the total. Shield Therapeutics Inc paid the most, $4,472.

Dr. Diep graduated from Renaissance School of Medicine at Stony Brook University in 2015.

Dr. Diep is in network with 8 carriers, including Aetna, Blue Cross Blue Shield of Massachusetts and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 4. Check the plan with the practice before a visit.